Literature DB >> 27896578

Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database.

M May1, C Protzel2, M W Vetterlein3, M Gierth4, J Noldus5, A Karl6, T Grimm6, B Wullich7, M O Grimm8, P Nuhn9, P J Bastian10, J Roigas11, B Hadaschik12, C Gilfrich13, M Burger4, M Fisch3, S Brookman-May6, A Aziz3, O W Hakenberg2.   

Abstract

PURPOSE: To evaluate the possible association between bladder tumor location and the laterality of positive lymph nodes (LN) in a prospectively collected multi-institutional radical cystectomy (RC) series.
METHODS: The study population included 148 node-positive bladder cancer (BC) patients undergoing RC and pelvic lymph node dissection in 2011 without neoadjuvant chemotherapy and without distant metastasis. Tumor location was classified as right, left or bilateral and compared to the laterality of positive pelvic LN. A logistic regression model was used to identify predictors of ipsilaterality of lymphatic spread. Using multivariate Cox regression analyses (median follow-up: 25 months), the effect of the laterality of positive LN on cancer-specific mortality (CSM) was estimated.
RESULTS: Overall, median 18.5 LN [interquartile range (IQR), 11-27] were removed and 3 LN (IQR 1-5) were positive. There was concordance of tumor location and laterality of positive LN in 82% [95% confidence interval (CI), 76-89]. Patients with unilateral tumors (n = 78) harbored exclusively ipsilateral positive LN in 67% (95% CI 56-77). No criteria were found to predict ipsilateral positive LN in patients with unilateral tumors. CSM after 3 years in patients with ipsilateral, contralateral, and bilateral LN metastasis was 41, 67, and 100%, respectively (p = 0.042). However, no significant effect of the laterality of positive pelvic LN on CSM could be confirmed in multivariate analyses.
CONCLUSIONS: Our prospective cohort showed a concordance of tumor location and laterality of LN metastasis in BC at RC without any predictive criteria and without any influence on CSM. It is debatable, whether these findings may contribute to a more individualized patient management.

Entities:  

Keywords:  Cystectomy; Laterality of lymph node metastasis; Lymph node dissection; Tumor location; Urinary bladder neoplasms

Mesh:

Year:  2016        PMID: 27896578     DOI: 10.1007/s11255-016-1469-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  20 in total

1.  The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.

Authors:  Firas Abdollah; Maxine Sun; Shahrokh F Shariat; Jan Schmitges; Orchidee Djahangirian; Zhe Tian; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

2.  Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.

Authors:  Atiqullah Aziz; Matthias May; Maximilian Burger; Rein-Jüri Palisaar; Quoc-Dien Trinh; Hans-Martin Fritsche; Michael Rink; Felix Chun; Thomas Martini; Christian Bolenz; Roman Mayr; Armin Pycha; Philipp Nuhn; Christian Stief; Vladimir Novotny; Manfred Wirth; Christian Seitz; Joachim Noldus; Christian Gilfrich; Shahrokh F Shariat; Sabine Brookman-May; Patrick J Bastian; Stefan Denzinger; Michael Gierth; Florian Roghmann
Journal:  Eur Urol       Date:  2013-12-27       Impact factor: 20.096

Review 3.  Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.

Authors:  Lars Weisbach; Roland Dahlem; Giuseppe Simone; Jens Hansen; Armin Soave; Oliver Engel; Felix K Chun; Shahrokh F Shariat; Margit Fisch; Michael Rink
Journal:  Int Urol Nephrol       Date:  2013-07-25       Impact factor: 2.370

4.  Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study.

Authors:  Hassan Abol-Enein; Derya Tilki; Ahmed Mosbah; Mahmoud El-Baz; Ahmed Shokeir; Adel Nabeeh; Mohamed A Ghoneim
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

5.  Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.

Authors:  Matthias May; Edwin Herrmann; Christian Bolenz; Arne Tiemann; Sabine Brookman-May; Hans-Martin Fritsche; Maximilian Burger; Alexander Buchner; Christian Gratzke; Christian Wülfing; Lutz Trojan; Jörg Ellinger; Derya Tilki; Christian Gilfrich; Thomas Höfner; Jan Roigas; Mario Zacharias; Sven Gunia; Wolf F Wieland; Markus Hohenfellner; Maurice S Michel; Axel Haferkamp; Stefan C Müller; Christian G Stief; Patrick J Bastian
Journal:  Eur Urol       Date:  2011-01-28       Impact factor: 20.096

6.  Does extended lymphadenectomy increase the morbidity of radical cystectomy?

Authors:  C Brössner; A Pycha; A Toth; C Mian; W Kuber
Journal:  BJU Int       Date:  2004-01       Impact factor: 5.588

7.  The role of cystectomy in elderly patients - a multicentre analysis.

Authors:  Laura Izquierdo; Lluis Peri; Priscila Leon; Miguel Ramírez-Backhaus; Thomas Manning; Antonio Alcaraz; Morgan Roupret; Eduardo Solsona; Jose Rubio; Shomik Sengupta; Yee Chan; Peter Liodakis; Dennis Gyomber; Damien Bolton; Nathan Lawrentschuk
Journal:  BJU Int       Date:  2015-09-02       Impact factor: 5.588

Review 8.  Treatment of muscle-invasive bladder cancer: A systematic review.

Authors:  Roger Chou; Shelley S Selph; David I Buckley; Katie S Gustafson; Jessica C Griffin; Sara E Grusing; John L Gore
Journal:  Cancer       Date:  2016-01-15       Impact factor: 6.860

9.  Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer.

Authors:  K I Wishnow; D E Johnson; J Y Ro; D A Swanson; R J Babaian; A C von Eschenbach
Journal:  J Urol       Date:  1987-03       Impact factor: 7.450

10.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

View more
  2 in total

1.  The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.

Authors:  Sacit Nuri Gorgel; Osman Kose; Esra Meltem Koc; Erhan Ates; Yigit Akin; Yuksel Yilmaz
Journal:  Int Urol Nephrol       Date:  2017-07-01       Impact factor: 2.370

2.  Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.

Authors:  Xiaofeng Cheng; Xiaochen Zhou; Ming Yi; Song Xu; Cheng Zhang; Gongxian Wang
Journal:  BMC Urol       Date:  2021-09-27       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.